CNSDose is a pharmacogenomic test that optimises mental health medication selection by incorporating genetics that influence both liver metabolism and blood-brain barrier efflux. CNSDose seeks to improve drug efficacy and reduce side-effects by helping clinicians select appropriate medications and doses based on a patients genetic profile.
| Website | https://www.cnsdose.com |
| Employees | 6 (5 on RocketReach) |
| Founded | 2012 |
| Technologies |
HTML
,
Google Analytics
,
Google Tag Manager
+10 more
(view full list)
|
| Industry | Medical and Diagnostic Laboratories, Mental health, Health Care, Biotechnology |
| Keywords | Clinical Trial Data, Software As A Medical Device, Precision Medicine Software, Drug Response Prediction, Biomarker Discovery, Personalized Medicine, Predictive Medicine, Pharmacogenomics, Digital Therapeutics, Mental Health Software, Mental Health Technology, Clinical Decision Support, Healthcare It, Depression Treatment, Genetic Testing |
Looking for a particular CNSDose employee's phone or email?
Hayden Pitout is the CTO of CNSDose.
5 people are employed at CNSDose.
CNSDose is based in Melbourne, Victoria.